Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway

Activated T cells release bioactive Fas ligand (FasL) in exosomes, which subsequently induce self-apoptosis of T cells. However, their potential effects on cell apoptosis in tumors are still unknown. In this study, we purified exosomes expressing FasL from activated CD8+ T cell from OT-I mice and found that activated T cell exosomes had little effect on apoptosis and proliferation of tumor cells but promoted the invasion of B16 and 3LL cancer cells in vitro via the Fas/FasL pathway. Activated T cell exosomes increased the amount of cellular FLICE inhibitory proteins and subsequently activated the ERK and NF-κB pathways, which subsequently increased MMP9 expression in the B16 murine melanoma cells. In a tumor-invasive model in vivo, we observed that the activated T cell exosomes promoted the migration of B16 tumor cells to lung. Interestingly, pretreatment with FasL mAb significantly reduced the migration of B16 tumor cells to lung. Furthermore, CD8 and FasL double-positive exosomes from tumor mice, but not normal mice, also increased the expression of MMP9 and promoted the invasive ability of B16 murine melanoma and 3LL lung cancer cells. In conclusion, our results indicate that activated T cell exosomes promote melanoma and lung cancer cell metastasis by increasing the expression of MMP9 via Fas signaling, revealing a new mechanism of tumor immune escape.

[1]  K. Kwack,et al.  Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. , 2011, DNA and cell biology.

[2]  Clotilde Théry,et al.  Exosomes: immune properties and potential clinical implementations , 2011, Seminars in Immunopathology.

[3]  D. Kwong,et al.  Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway , 2011, Gut.

[4]  H. Toivonen,et al.  Modeling Reveals That Dynamic Regulation of c-FLIP Levels Determines Cell-to-Cell Distribution of CD95-mediated Apoptosis* , 2011, The Journal of Biological Chemistry.

[5]  I. B. Borel Rinkes,et al.  CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. , 2010, Journal of hepatology.

[6]  J. Xiang,et al.  Dendritic Cells Recruit T Cell Exosomes via Exosomal LFA-1 Leading to Inhibition of CD8+ CTL Responses through Downregulation of Peptide/MHC Class I and Fas Ligand-Mediated Cytotoxicity , 2010, The Journal of Immunology.

[7]  Yoo-Seok Yoon,et al.  Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis , 2010, Journal of Clinical Pathology.

[8]  Li-Ping Liu,et al.  The Role of NF-κB in Hepatitis B Virus X Protein-Mediated Upregulation of VEGF and MMPs , 2010, Cancer investigation.

[9]  Christine Feig,et al.  CD95/Fas promotes tumour growth , 2010, Nature.

[10]  L. Mincheva-Nilsson,et al.  REVIEW ARTICLE: The Role of Placental Exosomes in Reproduction , 2010, American journal of reproductive immunology.

[11]  I. Sancho-Martinez,et al.  CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. , 2010, Immunity.

[12]  T. Wang,et al.  Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver. , 2009, Gastroenterology.

[13]  J. Eriksson,et al.  PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability , 2009, Cell Death and Differentiation.

[14]  Xuetao Cao,et al.  Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE21 , 2009, Journal of Immunology.

[15]  S. Hedrick,et al.  The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival1 , 2008, The Journal of Immunology.

[16]  J. Serody,et al.  Tumorigenesis and Neoplastic Progression C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9 , 2010 .

[17]  I. Sancho-Martinez,et al.  Yes and PI3K bind CD95 to signal invasion of glioblastoma. , 2008, Cancer cell.

[18]  C. Shaha,et al.  Up-Regulation of Bcl-2 through ERK Phosphorylation Is Associated with Human Macrophage Survival in an Estrogen Microenvironment1 , 2007, The Journal of Immunology.

[19]  D. McMillin,et al.  Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation , 2006, Clinical Cancer Research.

[20]  Xuetao Cao,et al.  Efficient induction of antitumor T cell immunity by exosomes derived from heat‐shocked lymphoma cells , 2006, European journal of immunology.

[21]  Taoyong Chen,et al.  More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells , 2005, Clinical Cancer Research.

[22]  J. Xiang,et al.  CD4−8− Dendritic Cells Prime CD4+ T Regulatory 1 Cells to Suppress Antitumor Immunity1 , 2005, The Journal of Immunology.

[23]  D. Lawrence,et al.  Selective Knockdown of the Long Variant of Cellular FLICE Inhibitory Protein Augments Death Receptor-mediated Caspase-8 Activation and Apoptosis* , 2005, Journal of Biological Chemistry.

[24]  A. Viola,et al.  Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers , 2005, The Journal of experimental medicine.

[25]  P. Krammer,et al.  c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[26]  S. Orecchia,et al.  FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells , 2004, Oncogene.

[27]  M. Peter,et al.  CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.

[28]  H. Stein,et al.  c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis , 2004, The Journal of experimental medicine.

[29]  D. Green,et al.  Activation‐induced cell death in T cells , 2003, Immunological reviews.

[30]  Robert L Fine,et al.  Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. , 2003, Cancer research.

[31]  M. Heyman,et al.  The epithelial cell cytoskeleton and intracellular trafficking. II. Intestinal epithelial cell exosomes: perspectives on their structure and function. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[32]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[33]  M. Sporn,et al.  An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[34]  J. Tschopp,et al.  NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.

[35]  F. Martinon,et al.  The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways , 2000, Current Biology.

[36]  Y. Ikawa,et al.  Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. , 2000, Cancer research.

[37]  M. Martínez-Lorenzo,et al.  Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.

[38]  M. Cohen,et al.  Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. , 1998, Cancer research.

[39]  D. Ferrari,et al.  Apoptosis signaling by death receptors. , 1998, European journal of biochemistry.

[40]  H. Kalthoff,et al.  Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. , 1998, Cancer research.

[41]  J. Yanagisawa,et al.  The Molecular Interaction of Fas and FAP-1 , 1997, The Journal of Biological Chemistry.

[42]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[43]  A. Hayday,et al.  A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice , 1996, The Journal of experimental medicine.

[44]  R. Fridman,et al.  Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). , 1995, Cancer research.

[45]  John Calvin Reed,et al.  FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.

[46]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[47]  Sun-Mi Park,et al.  CD95 promotes tumour growth , 2011, Nature.

[48]  M. Peter,et al.  The CD95(APO-1/Fas) DISC and beyond , 2003, Cell Death and Differentiation.

[49]  Germaine Greer,et al.  van Deventer H , 1968 .